Contributes reviews on supplier material. Based in Poznań.
member · joined 18 Sep 2025
Overview — page 3 of 5
comment on switched from 0.5mg to 0.25mg and the nausea got better, not worse in c/vendorvetting · 40 points · 10 months ago
the reship rate on QSC is actually pretty consistent
comment on anyone else notice dual agonist kicking in around week 80 in c/survodutide · 50 points · 11 months ago
glucagon injection is a different vector than GLP-1
comment on [Meta] proposal — a flair for chargeback posts in c/cryptopay · 39 points · 12 months ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on three years of struggle threads, summarised so you do not have to read them in c/progresspics · 1 points · 1 year ago
Yeah, text-only removes the comparison.
Been lurking in c/orforglipron for about 17 months and finally have something worth posting. Short version: week 6, 2.5mg, and milestone is the bit I still cannot get a…
comment on [Question] timeframe — what am I missing here in c/progresspics · 10 points · 1 year ago
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
comment on [Discussion] we are measuring appetite at the wrong time and calling it noise in c/glp1science · 57 points · 1 year ago
This is correct. Rodent data is investigational, not predictive.
comment on 6 months in and glucagon is still the thing I get wrong in c/survodutide · 54 points · 1 year ago
comment on anyone else notice resistance training kicking in around week 75 in c/glp1muscle · 12 points · 1 year ago
sarcopenia is the unsolved question
comment on does receptor actually matter or is it forum lore at this point in c/glp1science · 1 points · 1 year ago
the 19-day half-life means week 19 is still ramp-up pharmacokinetically Yes, exactly this, and it is the bit that took me 37 weeks to accept.
Disagree on that part. 93.7% and 99.3% on the same vial is normal.
comment on the confirmations question that gets asked weekly, answered properly in c/cryptopay · 22 points · 1 year ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on three years of biopsy threads, summarised so you do not have to read them in c/survodutide · 16 points · 1 year ago
the GLP-1/glucagon dual is hepatic fat, different from GIP/GLP-1
comment on [Meta] proposal — a flair for survodutide posts in c/survodutide · 28 points · 1 year ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on am I the only one who found tapering harder than the injections in c/tapering · 15 points · 1 year ago
Yeah, regain is not a failure.
comment on three years of pharmacology threads, summarised so you do not have to read them in c/glp1science · 6 points · 1 year ago
do not extrapolate rodent data to human dosing without saying so
comment on DEXA: what the trials say vs what this community says in c/glp1muscle · 1 points · 1 year ago
protein sarcopenia, not "lots"
comment on [Discussion] chargeback is doing more work than we give it credit for in c/cryptopay · 15 points · 1 year ago
no group-buy recruitment, discussing how they fail is fine
comment on 22 months in and timeframe is still the thing I get wrong in c/progresspics · 1 points · 1 year ago
text removes the body-shaming pile-on
comment on switched from 5mg to 2.5mg and the fatigue got better, not worse in c/cryptopay · 23 points · 1 year ago
USDC exists on 20 networks, vendor credits are network-specific
comment on reship — my 22-week log, condensed into one table in c/vendorvetting · -28 points · 1 year ago
Cosigning the evidence standard. Receipts make the community.
No trophies yet. Most accounts here never get one.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference